Examples of founding and evolving leading LifeScience companies. November 2016

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Examples of founding and evolving leading LifeScience companies. November 2016"

Transcription

1 Examples of founding and evolving leading LifeScience companies November 2016

2 Peter Pohl Born: in Salzburg Love: my wife and my two children (age 9&7) Education: Business Adminstration Serial entrepreneur Passion: Founding of companies, growth of companies, leadership, consultancy Place of Living: The Bodensee 2 IDEAHUB TRILAGO November 2016

3 The beginning 3 IDEAHUB TRILAGO November 2016

4 Foto Hinterhof Fritz-Arnold-Strasse 4 IDEAHUB TRILAGO November 2016

5 GATC Headquarter Konstanz 5 IDEAHUB TRILAGO November 2016

6 GATC Biotech Innovation management throughout the years New technologies allow better insights and deeper understanding of scientific requirements. 1 st NGS service provider Today GATC-Böxle TM World s first non-radioactive sequencing technology 1 st 24h sequencing service GATCLIQUID TM Realisation of personalised medicine Multiplatform (PacBio + HiSeq + MiSeq) 6 IDEAHUB TRILAGO November 2016

7 Our service workflow enables high-quality research Online platform Efficient logistic solutions Sequencing, assembly & analysis Customer Hotline; NextGen projects supervised by project management All tubes/plates carry barcode labels 7 IDEAHUB TRILAGO November 2016 Automated production processes Data delivery via secured mygatc account

8 Production: The power horses at GATC European Custom Sequencing Center, Cologne, Germany Genome and Diagnostic Centre, Constance, Germany Fastest Sanger sequencing service in Europe ISO accredited Swift logistics Overnight service Next-generation sequencing on all prevalent technologies INVIEW standardised NGS ISO / ISO Certified Service Provider of Illumina and PacBio ~ samples p.a. ~ samples p.a. 8 IDEAHUB TRILAGO November 2016

9 European wide sales and production structure We have subsidiaries, labs and sales offices in Germany (incl. Labs) Great Britain France Sweden and customers in over 30 countries 9 IDEAHUB TRILAGO November 2016

10 Product Portfolio: GATC Sequencing Solutions overview Sanger sequencing Next Generation Sequencing Flexibility in services, delivery times and batch size NightXpress TM Tubes or 96-well format LIFE TECHNOLOGIES HUMAN EXOME AMPLICON TRANSCRIPTOME EPIGENOME MODIFICATION ANALYSIS DE NOVO GENOME MICROBIOME Pacific Bioscience Pre-Sequencing Library Sequencing Bio-IT Illumina 10 IDEAHUB TRILAGO November 2016

11 Uniqueness of GATC Biotech GATC is the No. 1 Service Provider of DNA and RNA sequencing in Europe since 25 years Family owned business in the molecular diagnostics area Experience and loyalty of Management Excellent network in the academic and medical space with more then customers High reputation and strong, well-known brand GATC runs a profitable core business with strong upside opportunities in molecular diagnostics First-Mover experience (new technologies, LifeCodexx, Liquid Biopsy) Successful entry in the diagnostics market with LifeCodexx Scaling and optimizing processes in the molecular biology area Patents and proprietary processes & algorithms (GATC- LIMS, PraenaTest, PraenaBoxx) Accreditated processes with ISO 17025, ISO 13485, ISO 9001; Certified Service Provider of Agilent, Illumina and Pacific Biosciences; potential CAP/CLIA accreditation 11 IDEAHUB TRILAGO November 2016

12 GATCLIQUID The Liquid Biopsy Service Line of GATC

13 Limitations of tissue biopsy Biopsy is invasive May not be feasible based on patient condition or tumour accessibility Impractical for periodic monitoring for progression recurrence Biopsy tissue is often very limited Greater demand due to molecular profiling Surgery is costly Example Cancer: heterogeneous disease Molecular properties differ within tumours Therapy causes changes in tumour cells 13 IDEAHUB TRILAGO November 2016

14 The principle of liquid biopsy 14 IDEAHUB TRILAGO November 2016

15 Liquid Biopsy The X-Ray of the 21 st century Liquid Biopsy is non-invasive declining need for operations for diagnostic purpose Body fluids are easier and less costly to collect compared to solid biopsies Growing interest in research brings Liquid Biopsy in clinical environment Liquid biopsies have the potential to replace traditional invasive diagnostics methods that are often ineffective or nearly impossible to perform. By improving the outcome for cancer patients, liquid biopsy can ultimately become the X-ray of the 21st century. 15 IDEAHUB TRILAGO November 2016

16 GATCLIQUID: GATC s research services for cancer research and diagnosis ONCOEXOME ONCOPANEL ONCOTARGET Unbiased discovery Exome sequencing of matched samples from tumour tissue, cell-free DNA and blood Targeted screening Panel sequencing of clinically actionable mutations, including low frequency mutations Monitoring Frequent detection of single driver mutations after treatment, such as surgery or therapy 16 IDEAHUB TRILAGO November 2016

17 GATCLIQUID services follows the cancer treatment timeline Screening Diagnosis Treatment Follow-up STAGING SURGERY CHEMO RADIATION RECUPERATION Biopsy Imaging Tumour size Molecular stratification Tumour removal Irradiance Medication Monitoring GATCLIQUID Diagnosis ONCOEXOME Adjuvant treatment decision Companion diagnostics Measurement of therapeutic response Follow-up ONCOPANEL ONCOTARGET 17 IDEAHUB TRILAGO November 2016

18 LifeCodexx Establishing Market Leadership with Liquid Biopsy in Prenatal Diagnostics

19 Market Opportunity Non-invasive prenatal testing (NIPT) is the safest and most accurate option to test for genetic abnormalities during pregnancy 19

20 PrenaTest NGS NIPT for detection of fetal trisomies T21, T13, T18 and more First NIPT to enter the European market when it was launched in August 2012 following clinical validation Originally (at launch) focused on the detection of fetal trisomy T21; test capabilities have since been extended to detect T13, T18, gonosomal aneuploides and multiple pregnancies Only NIPT in Europe for the detection of the indicators listed above that is performed in accordance with the In-Vitro Diagnostics Directive 98/79/EG of the European Union (requires both CE-marked analysis software and a full quality assurance system) Utilizes Massively Parallel Sequencing (MPS), which is typically accepted as one of the best validated methods for NIPT Currently available in 35 countries across Europe, the Middle East and Asia Currently holds either the number one or two market position in all active territories Recently launched in Italy, Belgium, Serbia, Slovenia, Croatia, Macedonia, Montenegro, Ukraine, Greece, Portugal with ongoing launches in Russia, India, Vietnam and Spain Analysis includes the use of both LifeCodexx proprietary QuantYfeX assay (for quantification of fetal DNA at the beginning of the analysis) and PrenaTest DAP.plus analysis software (for bioinformatic analysis of the sequencing data) Applied for reimbursement in Germany and Switzerland submitted in 2013 and in Hungary in 2015; received statutory reimbursement in Switzerland in 2015 and Germany and Hungary are pending Initiated a Post Marketing Clinical Follow-Up (PMCF) study with the University of Bonn in Germany; aim is to determine the birth outcome of ~2,000 patients - more than 1,500 patients recruited to date 20

21 Challenges during Founding & Evolving Get the product DBE / Services / PrenaTest Get the investment Own money Customer Public funds Other people s money ( OPM ): VC / PE / Family Office / F&F Get the right team More important than product and money!! Get the customer the only one that brings in money (if you want to earn money) Get the grip Think first and then move, move, move Move the bottlenecks or they will move you 21 IDEAHUB TRILAGO November 2016

22 Thank you! 22 IDEAHUB TRILAGO November 2016

Next Generation Sequencing (NGS) Market Size, Growth and Trends ( )

Next Generation Sequencing (NGS) Market Size, Growth and Trends ( ) Next Generation Sequencing (NGS) Market Size, Growth and Trends (2014-2020) July, 2017 4 th edition Information contained in this market report is believed to be reliable at the time of publication. DeciBio

More information

resequencing storage SNP ncrna metagenomics private trio de novo exome ncrna RNA DNA bioinformatics RNA-seq comparative genomics

resequencing storage SNP ncrna metagenomics private trio de novo exome ncrna RNA DNA bioinformatics RNA-seq comparative genomics RNA Sequencing T TM variation genetics validation SNP ncrna metagenomics private trio de novo exome mendelian ChIP-seq RNA DNA bioinformatics custom target high-throughput resequencing storage ncrna comparative

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases

More information

Redefining NIPT as we know it.

Redefining NIPT as we know it. Redefining NIPT as we know it. The VeriSeq NIPT Solution. One comprehensive workflow. Rachel Felt reassurance with NIPT Taking NIPT to a new level A revolutionary in-lab method from Illumina Excellent

More information

DNA. bioinformatics. epigenetics methylation structural variation. custom. assembly. gene. tumor-normal. mendelian. BS-seq. prediction.

DNA. bioinformatics. epigenetics methylation structural variation. custom. assembly. gene. tumor-normal. mendelian. BS-seq. prediction. Epigenomics T TM activation SNP target ncrna validation metagenomics genetics private RRBS-seq de novo trio RIP-seq exome mendelian comparative genomics DNA NGS ChIP-seq bioinformatics assembly tumor-normal

More information

Next Generation Sequencing. Target Enrichment

Next Generation Sequencing. Target Enrichment Next Generation Sequencing Target Enrichment Next Generation Sequencing Your Partner in Every Step from Sample to Data NGS: Revolutionizing Genetic Analysis with Single-Molecule Resolution Next generation

More information

First Annual Biomarker Symposium Quest Diagnostics Clinical Trials

First Annual Biomarker Symposium Quest Diagnostics Clinical Trials First Annual Biomarker Symposium Quest Diagnostics Clinical Trials Terry Robins, Ph.D. Director Biomarker R&D and Scientific Affairs Quest Diagnostics Clinical Trials Key Considerations: Biomarker Development

More information

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing

More information

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution

More information

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298

TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES March 2017. March 2017 ABA 298 1 Technologies, Products & Services

More information

WELCOME. Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS)

WELCOME. Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS) WELCOME Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS) Director, UB Genomics and Bioinformatics Core (GBC) o o o o o o o o o o o o Grow

More information

Global In-Vitro Diagnostics (IVD) Market Report

Global In-Vitro Diagnostics (IVD) Market Report Global In-Vitro Diagnostics (IVD) Market Report ----------------------------------------- 215 Executive Summary The diagnostic industry is widely classified into two types: In-vitro diagnostics and In-vivo

More information

GLOBAL VIDEO-ON- DEMAND (VOD)

GLOBAL VIDEO-ON- DEMAND (VOD) GLOBAL VIDEO-ON- DEMAND (VOD) HOW WORLDWIDE VIEWING HABITS ARE CHANGING IN THE EVOLVING MEDIA LANDSCAPE MARCH 2016 A CHANGING VIDEO-VIEWING LANDSCAPE Nearly two-thirds of global respondents say they watch

More information

Introduction. High Clinical Accuracy. Prep are Lib rary Seq uence Analyze Data. Highlights

Introduction. High Clinical Accuracy. Prep are Lib rary Seq uence Analyze Data. Highlights VeriSeq NIPT Solution Revolutionizing NIPT, the VeriSeq NIPT Solution is a comprehensive, ready-to-use, wholegenome sequencing assay that generates accurate results for up to 96 samples in ~ 1 day. Highlights

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce

More information

Targeted Sequencing in the NBS Laboratory

Targeted Sequencing in the NBS Laboratory Targeted Sequencing in the NBS Laboratory Christopher Greene, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Gene Sequencing in Public Health Newborn Screening February

More information

Complementary Technologies for Precision Genetic Analysis

Complementary Technologies for Precision Genetic Analysis Complementary NGS, CGH and Workflow Featured Publication Zhu, J. et al. Duplication of C7orf58, WNT16 and FAM3C in an obese female with a t(7;22)(q32.1;q11.2) chromosomal translocation and clinical features

More information

TIME IT S PRIME. chemagic TM Prime TM instrument Streamlined Walk-away Automation. For all Human Sample Materials. Primary Sample Handling

TIME IT S PRIME. chemagic TM Prime TM instrument Streamlined Walk-away Automation. For all Human Sample Materials. Primary Sample Handling IT S PRIME TIME chemagic TM Prime TM instrument Streamlined Walk-away Automation. For all Human Sample Materials. Primary Sample Nucleic Acid Isolation Eluate Quantitation of Extracted Samples Assay Setup

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics Alla L Lapidus, Ph.D. SPbSU St. Petersburg Term Bioinformatics Term Bioinformatics was invented by Paulien Hogeweg (Полина Хогевег) and Ben Hesper in 1970 as "the study of

More information

Dedicated to Molecular Diagnostics

Dedicated to Molecular Diagnostics Dedicated to Molecular Diagnostics For Europe Sample & Assay Technologies QIAGEN s growing role in molecular diagnostics At QIAGEN, one of our key goals is to support clinical decision-making and improve

More information

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS

More information

Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies

Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies Personalised Healthcare Solutions (PHCS) Excellence for your Biomarker-driven Strategies The value of In Vitro Diagnostics The value of diagnostics as an integral part in the healthcare value chain Diagnostics

More information

Trans-omics for a better life

Trans-omics for a better life Trans-omics for a better life History From 1% to World Leading The largest genomic organization in the world Focus on research and applications in the healthcare, agriculture, conservation, and environmental

More information

SPRIworks Systems. Push button. Walk away. Fully automated library construction systems with built-in size selection and cleanup BR-15981B

SPRIworks Systems. Push button. Walk away. Fully automated library construction systems with built-in size selection and cleanup BR-15981B SPRIworks Systems Fully automated library construction systems with built-in size selection and cleanup Push button. Walk away. BR-15981B SPRIworks Technology Fully automated fragment library construction

More information

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS THE DOORS ARE OPEN: FEEL FREE TO COME IN CENTOGENE UNLOCKS THE POWER OF GENETIC INSIGHTS TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH GENETIC

More information

Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends ( )

Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends ( ) Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends (2013-2021) May, 2017 3 rd Edition Information contained in this market report is believed to be reliable at the time

More information

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary

More information

The European Medical Technology Industry. in figures / 2018

The European Medical Technology Industry. in figures / 2018 The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in

More information

Welcome to the NGS webinar series

Welcome to the NGS webinar series Welcome to the NGS webinar series Webinar 1 NGS: Introduction to technology, and applications NGS Technology Webinar 2 Targeted NGS for Cancer Research NGS in cancer Webinar 3 NGS: Data analysis for genetic

More information

Roche in Switzerland

Roche in Switzerland Roche in Switzerland A leader around the world and at home Last year Roche employed some 13,000 employees from over 90 countries in Switzerland. This makes Switzerland one of Roche s three largest locations

More information

Connecting Europe: Customer needs along the value added chain

Connecting Europe: Customer needs along the value added chain Connecting Europe: Customer needs along the value added chain 2 Austria General information Population: 8.40.000 BIP per Capita: GDP Growth rate 2,2 % (2005 est.) 27.900 EUR 3 Austrian Post Key figures

More information

COPE. FAQs CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES

COPE. FAQs CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES COPE CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES FAQs This brochure addresses FAQ and is prepared solely for the German market. Local adjustments may be necessary. Please contact us if you require additional

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

LiquidBiopsy LIQUIDBIOPSY. Automated Rare Template Isolation Platform

LiquidBiopsy LIQUIDBIOPSY. Automated Rare Template Isolation Platform LiquidBiopsy LIQUIDBIOPSY Automated Rare Template Isolation Platform Enabling cancer research with highly multiplexed molecular analysis of serially collected blood samples The LiquidBiopsy Platform simplifies

More information

Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL

Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL James Storhoff, Ph.D. Senior Manager, Diagnostic Test Development World Cdx, Boston, Sep. 10th Molecules That

More information

Corporate Presentation. February 2, 2018

Corporate Presentation. February 2, 2018 Corporate Presentation February 2, 2018 Forward Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements

More information

The Community Innovation Survey 2010

The Community Innovation Survey 2010 The Community Innovation Survey 2010 (CIS 2010) THE HARMONISED SURVEY QUESTIONNAIRE The Community Innovation Survey 2010 FINAL VERSION July 9, 2010 This survey collects information on your enterprise s

More information

Illumina Diagnostics. Emily Winn-Deen, PhD Vice President, Product Development Diagnostics

Illumina Diagnostics. Emily Winn-Deen, PhD Vice President, Product Development Diagnostics Introduction ti to Illumina Diagnostics Emily Winn-Deen, PhD Vice President, Product Development Diagnostics 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,

More information

CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY

CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY CALIFORNIA S BIOTECHNOLOGY WORKFORCE TRAINING NEEDS FOR THE 21 st CENTURY Executive Summary Prepared for Applied Biological Technologies Initiative Economic and Workforce Development Program California

More information

Admera Health RUO Services

Admera Health RUO Services Admera Health RUO Services Services 1. RNA-Seq... 2 2. Single-cell RNAseq (scrna-seq)... 3 3. Whole Exome Sequencing (WES)... 4 4. Whole Genome Sequencing (WGS)... 5 5. Whole Genome Bisulfite Sequencing

More information

Outline. General principles of clonal sequencing Analysis principles Applications CNV analysis Genome architecture

Outline. General principles of clonal sequencing Analysis principles Applications CNV analysis Genome architecture The use of new sequencing technologies for genome analysis Chris Mattocks National Genetics Reference Laboratory (Wessex) NGRL (Wessex) 2008 Outline General principles of clonal sequencing Analysis principles

More information

Solution Partner Program Global Perspective

Solution Partner Program Global Perspective Solution Partner Program Global Perspective SPACe 2012 Siemens Process Automation Conference Business Development Solution Partner Program Copyright Siemens AG 2012. All rights reserved Solution Partner

More information

Konica Minolta to Acquire Invicro (US)

Konica Minolta to Acquire Invicro (US) Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September

More information

Fundamentals of Next-Generation Sequencing: Technologies and Applications

Fundamentals of Next-Generation Sequencing: Technologies and Applications Fundamentals of Next-Generation Sequencing: Technologies and Applications Society for Hematopathology European Association for Haematopathology 2017 Workshop Eric Duncavage, MD Washington University in

More information

Next-Generation Sequencing Services à la carte

Next-Generation Sequencing Services à la carte Next-Generation Sequencing Services à la carte www.seqme.eu ngs@seqme.eu SEQme 2017 All rights reserved The trademarks and names of other companies and products mentioned in this brochure are the property

More information

HLA-Typing Strategies

HLA-Typing Strategies HLA-Typing Strategies Cologne, 13.5.2017 Joannis Mytilineos MD, PhD Department of Transplantation Immunology Institute for Clinical Transfusion Medicine and Immunogenetics German Red Cross Blood Transfusion

More information

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you

More information

13 15 SEPTEMBER 2017 SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN

13 15 SEPTEMBER 2017 SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN 13 15 SEPTEMBER 2017 BARCELONA CONGRESS CENTRE, BARCELONA, SPAIN SERVING LABORATORY MANAGEMENT & DIOGNOSTIC NETWORKS GLOBALLY www.medlabeurope.com medlabeurope@informa.com +34 518890041 INTRODUCTION It

More information

DNA-Sequencing. Technologies & Devices. Matthias Platzer. Genome Analysis Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)

DNA-Sequencing. Technologies & Devices. Matthias Platzer. Genome Analysis Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) DNA-Sequencing Technologies & Devices Matthias Platzer Genome Analysis Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Genome analysis DNA sequencing platforms ABI 3730xl 4/2004 & 6/2006 1 Mb/day,

More information

Molecular Diagnostics: Market Segmentation and Opportunities

Molecular Diagnostics: Market Segmentation and Opportunities Molecular Diagnostics: Market Segmentation and Opportunities October 2010 This market report is published by DeciBio, LLC. All rights reserved. Reproduction or redistribution of this report in any form

More information

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend

Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Growing Needs for Practical Molecular Diagnostics: Indonesia s Preparedness for Current Trend Dr. dr. Francisca Srioetami Tanoerahardjo, SpPK., MSi Essential Practical Molecular Diagnostics Seminar Hotel

More information

The In Vitro Diagnostic CRO

The In Vitro Diagnostic CRO The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro

More information

DNA-Sequencing. Technologies & Devices. Matthias Platzer. Genome Analysis Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)

DNA-Sequencing. Technologies & Devices. Matthias Platzer. Genome Analysis Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) DNA-Sequencing Technologies & Devices Matthias Platzer Genome Analysis Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Genome analysis DNA sequencing platforms ABI 3730xl 4/2004 & 6/2006 1 Mb/day,

More information

Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA

Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA Safe Habor Statement All statements in this presentation not referring to historical

More information

QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd

QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd 1 Our current NGS & Bioinformatics Platform 2 Our NGS workflow and applications 3 QIAGEN s

More information

New Tools for the Enhanced

New Tools for the Enhanced New Tools for the Enhanced Management of Chronic Disease Based on a Proprietary, Point of Care, Electrochemical Detection System Universal Biosensors Investor Presentation February 2010 1 Important disclaimer

More information

Konica Minolta to Acquire Ambry Genetics (US)

Konica Minolta to Acquire Ambry Genetics (US) Konica Minolta to Acquire Ambry Genetics (US) Full-fledged Entry into Precision Medicine July 6, 2017 0 1. Transaction Details and Positioning in KM s Strategy 2. Full-fledged Entry into Precision Medicine

More information

Lab methods: Exome / Genome. Ewart de Bruijn

Lab methods: Exome / Genome. Ewart de Bruijn Lab methods: Exome / Genome 27 06 2013 Ewart de Bruijn Library prep is only a small part of the complete DNA analysis workflow DNA isolation library prep enrichment flowchip prep sequencing bioinformatics

More information

Making More Efficient Use of Biospecimens. ISBER Contributions and Initiatives

Making More Efficient Use of Biospecimens. ISBER Contributions and Initiatives Making More Efficient Use of Biospecimens. ISBER Contributions and Initiatives Members of the ISBER Education and Training Committee a,1, Members of the ISBER Science Policy a,1, Members of the ISBER Biospecimen

More information

Impact of gdna Integrity on the Outcome of DNA Methylation Studies

Impact of gdna Integrity on the Outcome of DNA Methylation Studies Impact of gdna Integrity on the Outcome of DNA Methylation Studies Application Note Nucleic Acid Analysis Authors Emily Putnam, Keith Booher, and Xueguang Sun Zymo Research Corporation, Irvine, CA, USA

More information

Proteomics And Cancer Biomarker Discovery. Dr. Zahid Khan Institute of chemical Sciences (ICS) University of Peshawar. Overview. Cancer.

Proteomics And Cancer Biomarker Discovery. Dr. Zahid Khan Institute of chemical Sciences (ICS) University of Peshawar. Overview. Cancer. Proteomics And Cancer Biomarker Discovery Dr. Zahid Khan Institute of chemical Sciences (ICS) University of Peshawar Overview Proteomics Cancer Aims Tools Data Base search Challenges Summary 1 Overview

More information

Ion S5 and Ion S5 XL Systems

Ion S5 and Ion S5 XL Systems Ion S5 and Ion S5 XL Systems Targeted sequencing has never been simpler Explore the Ion S5 and Ion S5 XL Systems Adopting next-generation sequencing (NGS) in your lab is now simpler than ever The Ion S5

More information

Surely Better Target Enrichment from Sample to Sequencer and Analysis

Surely Better Target Enrichment from Sample to Sequencer and Analysis sureselect TARGET ENRIChment solutions Surely Better Target Enrichment from Sample to Sequencer and Analysis Agilent s market leading SureSelect platform provides a complete portfolio of catalog to custom

More information

GRI Sustainability Reporting Statistics Publication year By Report Services

GRI Sustainability Reporting Statistics Publication year By Report Services GRI Sustainability Reporting Statistics Publication year 2010 By Report Services GRI reports 1999-2010 2000 1800 1600 1400 1200 1000 800 600 400 200 0 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

More information

CM581A2: NEXT GENERATION SEQUENCING PLATFORMS AND LIBRARY GENERATION

CM581A2: NEXT GENERATION SEQUENCING PLATFORMS AND LIBRARY GENERATION CM581A2: NEXT GENERATION SEQUENCING PLATFORMS AND LIBRARY GENERATION Fall 2015 Instructors: Coordinator: Carol Wilusz, Associate Professor MIP, CMB Instructor: Dan Sloan, Assistant Professor, Biology,

More information

IBBL: Introduction to Biobanks and their services

IBBL: Introduction to Biobanks and their services IBBL: Introduction to Biobanks and their services HighTech meets Health, Oss (NL), 15 th June 2017 Monica Marchese, PhD Biomarker Validation Scientist AN ACCREDITED & CERTIFIED BIOBANK INFRASTRUCTURE FOR

More information

The Worldwide Alpha-1 Antitrypsin Market. Present Situation and Future Prospects

The Worldwide Alpha-1 Antitrypsin Market. Present Situation and Future Prospects The Worldwide Alpha-1 Antitrypsin Market Present Situation and Future Prospects 2005-2015 TABLE OF CONTENTS November 2005 TABLE OF CONTENTS Executive Summary 15 Introduction. 33 Description, Background

More information

ACCEL-NGS 2S DNA LIBRARY KITS

ACCEL-NGS 2S DNA LIBRARY KITS ACCEL-NGS 2S DNA LIBRARY KITS Accel-NGS 2S DNA Library Kits produce high quality libraries with an all-inclusive, easy-to-use format. The kits contain all reagents necessary to build high complexity libraries

More information

Siemens Partner Program

Siemens Partner Program Siemens Partner Program Factory Automation Partner Strategy for Factory Automation End Customer Focus on core competencies Demand on efficient solutions Certified Partner Added value in solutions and services

More information

Synthetic Biology and Patents

Synthetic Biology and Patents Synthetic Biology and Patents Dr. Berthold Rutz, Directorate 2.4.01 Biotechnology European Patent Office Munich "Patenting Synthetic Biology? A Transatlantic Perspective" WWICS, Washington D.C. 30.11.2009

More information

2017 FYR April 13, 2018

2017 FYR April 13, 2018 2017 FYR April 13, 2018 Disclaimer The presentation and the information it contains do not constitute an offer to sell or subscribe for on the solicitation of an offer to buy or subscribe for securities

More information

Roche in Australia Innovation Leader

Roche in Australia Innovation Leader Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving

More information

Role of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy

Role of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy Role of an OIE Reference Laboratory Trichinellosis Edoardo Pozio Istituto Superiore di Sanità Rome, Italy Historical background The OIE Reference Laboratory for Trichinellosis was appointed at the Istituto

More information

Exeter s experience of trying to keep up with demand for NGS. Anna Bussell

Exeter s experience of trying to keep up with demand for NGS. Anna Bussell Exeter s experience of trying to keep up with demand for NGS Anna Bussell Overview Sample received and DNA extracted Admin & test review NGS wet lab work Sequencing Report authorisation & distribution

More information

Water Networks Management Optimization. Energy Efficiency, WaterDay Greece, Smart Water. Restricted / Siemens AG All Rights Reserved.

Water Networks Management Optimization. Energy Efficiency, WaterDay Greece, Smart Water. Restricted / Siemens AG All Rights Reserved. Water Networks Management Optimization. Energy Efficiency, WaterDay Greece, 2014 Smart Water siemens.com/answers Solution Partner Strategy I IA/DT Customer Solution oriented Focus on Core competencies

More information

GENERAL PAYER CONSIDERATIONS FOR NEW HEALTH TECHNOLOGIES (INCLUDING DIAGNOSTICS)

GENERAL PAYER CONSIDERATIONS FOR NEW HEALTH TECHNOLOGIES (INCLUDING DIAGNOSTICS) FORUM Payer perspectives and actions impacting diagnostics in the US and Europe Eric Faulkner, MPH Director, Quintiles Global Market Access Consulting; Executive Director, Genomics Biotech Emerging Medical

More information

The European Medical Technology Industry in figures

The European Medical Technology Industry in figures The European Medical Technology Industry in figures Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in Europe

More information

BIOMARKERS - ADVANCED TECHNOLOGIES AND GLOBAL MARKET ( )

BIOMARKERS - ADVANCED TECHNOLOGIES AND GLOBAL MARKET ( ) BIOMARKERS - ADVANCED TECHNOLOGIES AND GLOBAL MARKET (2009-2014) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r

More information

Implementation of Automated Sample Quality Control in Whole Exome Sequencing

Implementation of Automated Sample Quality Control in Whole Exome Sequencing Journal of Life Sciences 11 (2017) 261-268 doi: 10.17265/1934-7391/2017.06.001 D DAVID PUBLISHING Implementation of Automated Sample Quality Control in Whole Exome Sequencing Elisa Viering 1, Jana Molitor

More information

Applications of Next Generation Sequencing in Metagenomics Studies

Applications of Next Generation Sequencing in Metagenomics Studies Applications of Next Generation Sequencing in Metagenomics Studies Francesca Rizzo, PhD Genomix4life Laboratory of Molecular Medicine and Genomics Department of Medicine and Surgery University of Salerno

More information

Course Overview: Mutation Detection Using Massively Parallel Sequencing

Course Overview: Mutation Detection Using Massively Parallel Sequencing Course Overview: Mutation Detection Using Massively Parallel Sequencing From Data Generation to Variant Annotation Eliot Shearer The Iowa Initiative in Human Genetics Bioinformatics Short Course 2012 August

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

Genetic Testing in Insurance: A Medical View a

Genetic Testing in Insurance: A Medical View a Genetic Testing in Insurance: A Medical View a David Moss FIA SVP, Swiss Re Canada a Florian Rechfeld PhD Medical Biochemist, L&H R&D, Swiss Re a Loraine Oman-Ganes MD, FRCPC Chief Medical Director, Sun

More information

Q Presentation , Oslo

Q Presentation , Oslo Q4 2017 Presentation 01.02.2018, Oslo Agenda Highlights BetaGlucans Animal- and Consumer health Cancer Advanced wound care Enzymes Molecular and new markets Q4 Financials Outlook for 2018 2 Biotec in brief

More information

Introducing: 3Zomy Aneuploidity Test

Introducing: 3Zomy Aneuploidity Test Introducing: 3Zomy Aneuploidity Test QF-PCR Life Technologies (India) Pvt. Ltd. 306, Aggarwal City Mall, Opposite M2K Pitampura, Delhi 110034 (INDIA). Ph: +91-11-42208000, 4220811, 42208222 Mobile: +91-9810521400

More information

AMERICAN BOARD OF MEDICAL GENETICS

AMERICAN BOARD OF MEDICAL GENETICS AMERICAN BOARD OF MEDICAL GENETICS Logbook Guidelines for Certification in Clinical Molecular Genetics for the 2015 Examination Purpose: The purpose of the logbook is to document that the applicant has

More information

Raytheon Professional Services Training solutions that improve business performance

Raytheon Professional Services Training solutions that improve business performance Raytheon Professional Services solutions that improve business performance Raytheon Professional Services is a global leader in training services and outsourcing. We improve clients business performance

More information

Biomarkers for Delirium

Biomarkers for Delirium Biomarkers for Delirium Simon T. Dillon, Ph. D. Director of Proteomics BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center DF/HCC Proteomics Core Div. of Interdisciplinary Medicine and

More information

Global In-Vitro Diagnostic Market Report

Global In-Vitro Diagnostic Market Report Global In-Vitro Diagnostic Market Report ----------------------------------------------------- 2013 Executive Summary The process of performing a diagnostic test outside of a living organism in an artificial

More information

How much sequencing do I need? Emily Crisovan Genomics Core

How much sequencing do I need? Emily Crisovan Genomics Core How much sequencing do I need? Emily Crisovan Genomics Core How much sequencing? Three questions: 1. How much sequence is required for good experimental design? 2. What type of sequencing run is best?

More information

In 2013, global production

In 2013, global production 48 th Census of World Casting Production Steady Growth in Global Output Worldwide casting production continued to grow in 2013, up more than 3.4 million metric tons, an increase of 3.4% in comparison to

More information

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey PAREXEL GENOMIC MEDICINE SERVICES Applying genomics to enhance your drug development journey YOUR JOURNEY. OUR MISSION. Genomic expertise to simplify the route to product approval and maximize patient

More information

with drmid Dx for Illumina NGS systems

with drmid Dx for Illumina NGS systems Performance Characteristics BRCA MASTR Dx with drmid Dx for Illumina NGS systems Manufacturer Multiplicom N.V. Galileïlaan 18 2845 Niel Belgium Revision date: July 27, 2017 Page 1 of 8 Table of Contents

More information

Towards detection of minimal residual disease in multiple myeloma through circulating tumour DNA sequence analysis

Towards detection of minimal residual disease in multiple myeloma through circulating tumour DNA sequence analysis Towards detection of minimal residual disease in multiple myeloma through circulating tumour DNA sequence analysis Trevor Pugh, PhD, FACMG Princess Margaret Cancer Centre, University Health Network Dept.

More information

Genomic solutions for complex disease

Genomic solutions for complex disease Genomic solutions for complex disease Power your with our genomic solutions Access a breadth of applications. Gain a depth of insights. To enhance their understanding of complex disease, researchers are

More information

Personalized Medicine

Personalized Medicine Personalized Medicine Dr. Pablo Mentzinis, Director Government Relations, SAP SE Courtesy by Dominik Bertram, Marc von der Linden, Péter Adorján, SAP June 2016 1. Traditional medicine vs. personalized

More information

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013

Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Forthcoming Calls for Proposals (10/11) Barcelona 28 June 2013 Indicative list Proposed topic /11 /11 /11 Identification and validation of innovative clinical endpoints for Osteoarthritis European genotype-phenotype

More information

Laboratory Management for Clinical and Research NGS Labs

Laboratory Management for Clinical and Research NGS Labs Laboratory Management for Clinical and Research NGS Labs Introduction Few can argue that Next Generation Sequencing is having a major impact on genomics research. The progress in this field exceeds even

More information

Terminology for personalized medicine

Terminology for personalized medicine Terminology for personalized medicine Sarah Ali-Khan 1 PhD, Stephanie Kowal 2, Westerly Luth 2, Richard Gold 1 SJD, and Tania Bubela 2 PhD JD 1. Centre for Intellectual Property Policy (CIPP), Faculty

More information

WHILE A SMALL NUMBER OF PEOPLE ARE SUFFERING FROM A SINGLE RARE DISEASE, 350 MILLION PEOPLE WORLDWIDE ARE SUFFERING FROM RARE DISEASES.

WHILE A SMALL NUMBER OF PEOPLE ARE SUFFERING FROM A SINGLE RARE DISEASE, 350 MILLION PEOPLE WORLDWIDE ARE SUFFERING FROM RARE DISEASES. June 2017 WHILE A SMALL NUMBER OF PEOPLE ARE SUFFERING FROM A SINGLE RARE DISEASE, 350 MILLION PEOPLE WORLDWIDE ARE SUFFERING FROM RARE DISEASES. 3rd most populous country 50% of affected are children

More information